China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow Quality Index
China Resources Sanjiu Medical & Pharmaceutical Co Ltd cash flow quality index. China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Cash Flow Quality Index of 2.43x as of December 2025. Operating cash flow of CN¥2.60 Billion exceeds net income of CN¥1.07 Billion, indicating high earnings quality where cash backs reported profits. Explore 000999 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2025)
Cash flow quality index of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1999 to 2025. Historical Cash Flow Quality Index for China Resources Sanjiu Medical & Pharmaceutical Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 000999 equity financing ratio to measure how much of total assets are equity-financed.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow Quality Index by Year (1999–2025)
China Resources Sanjiu Medical & Pharmaceutical Co Ltd cash flow quality index by year from 1999 to 2025. Year-by-year earnings quality comparison for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 000999 cash flow metrics.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.61x | CN¥5.51 Billion | CN¥3.42 Billion | ▲ +38.3% |
| 2024 | 1.17x | CN¥4.40 Billion | CN¥3.78 Billion | ▼ -20.7% |
| 2023 | 1.47x | CN¥4.19 Billion | CN¥2.85 Billion | ▲ +19.7% |
| 2022 | 1.23x | CN¥3.01 Billion | CN¥2.45 Billion | ▲ +33.9% |
| 2021 | 0.92x | CN¥1.88 Billion | CN¥2.06 Billion | ▼ -33.3% |
| 2020 | 1.37x | CN¥2.22 Billion | CN¥1.62 Billion | ▲ +49.2% |
| 2019 | 0.92x | CN¥1.97 Billion | CN¥2.14 Billion | ▼ -28.9% |
| 2018 | 1.30x | CN¥1.91 Billion | CN¥1.47 Billion | ▲ +5.5% |
| 2017 | 1.23x | CN¥1.60 Billion | CN¥1.30 Billion | ▲ +6.6% |
| 2016 | 1.15x | CN¥1.39 Billion | CN¥1.21 Billion | ▲ +14.3% |
| 2015 | 1.01x | CN¥1.26 Billion | CN¥1.25 Billion | ▼ -8.7% |
| 2014 | 1.10x | CN¥1.18 Billion | CN¥1.07 Billion | ▼ -8.6% |
| 2013 | 1.21x | CN¥1.47 Billion | CN¥1.21 Billion | ▲ +7.8% |
| 2012 | 1.12x | CN¥1.21 Billion | CN¥1.08 Billion | ▼ -4.3% |
| 2011 | 1.17x | CN¥954.90 Million | CN¥815.13 Million | ▲ +18.6% |
| 2010 | 0.99x | CN¥848.28 Million | CN¥859.10 Million | ▼ -12.1% |
| 2009 | 1.12x | CN¥855.05 Million | CN¥761.59 Million | ▼ -45.6% |
| 2008 | 2.06x | CN¥1.12 Billion | CN¥541.14 Million | ▼ -3.2% |
| 2007 | 2.13x | CN¥605.30 Million | CN¥284.09 Million | ▼ -16.6% |
| 2006 | 2.55x | CN¥425.51 Million | CN¥166.56 Million | ▲ +1206.9% |
| 2005 | 0.20x | CN¥22.83 Million | CN¥116.77 Million | ▲ +55.2% |
| 2003 | 0.13x | CN¥28.09 Million | CN¥223.03 Million | ▼ -96.1% |
| 2002 | 3.23x | CN¥496.12 Million | CN¥153.45 Million | ▲ +161.6% |
| 2001 | 1.24x | CN¥153.44 Million | CN¥124.14 Million | ▼ -4.7% |
| 2000 | 1.30x | CN¥266.86 Million | CN¥205.76 Million | ▲ +147.8% |
| 1999 | 0.52x | CN¥120.63 Million | CN¥230.47 Million | — |